Donor-Derived Second Generation of CD19 CAR-T Cell Therapy for Relapsed B-Cell Acute Lymphoblastic Leukemia after Allogenic Stem Cell Transplantation

被引：7
|
作者：
Zhang, Rongli [1 ,2 ,3 ]
He, Yi [1 ,2 ,3 ]
Yang, Donglin [1 ,2 ,3 ]
Wang, Ying [2 ,4 ]
Feng, Sizhou [1 ,2 ,3 ]
Wang, Jianxiang [2 ,5 ]
Han, Ming-Zhe [1 ,2 ,3 ]
机构：
[1] CAMS, Stem Cell Transplantat Ctr, Inst Hematol, Tianjin, Peoples R China
[2] CAMS, Hosp Blood Dis, Tianjin, Peoples R China
[3] PUMC, Tianjin, Peoples R China
[4] Chinese Acad Med Sci, Leukemia Ctr, Inst Hematol, Tianjin, Peoples R China
[5] Chinese Acad Med Sci, State Key Lab Expt Hematol, Inst Hematol, Tianjin, Peoples R China
来源：
BLOOD | 2018年 / 132卷
关键词：
donor-derived CD19 CAR-T cell therapy; allogenic stem cell transplantation; B cell acute lymphoblastic leukemia; relapse;
D O I：
10.1182/blood-2018-99-114950
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2179
引用
下载
收藏
页数：2
相关论文
共 50 条
  • [21] Feasibility, and Efficacy of Donor-Derived cd19-Targeted Car t-Cell Therapy in Refractory/Relapsed(r/r)b-Cell Acute Lymphoblastic Leukemia (ball) Patients
    Zhang, Xian
    Yang, Junfang
    Li, Wenqian
    Zhang, Gailing
    Su, Yunchao
    Shi, Yanze
    Song, Dan
    Zhang, Min
    He, Jiujiang
    Xu, Li
    Qiu, Liyuan
    Lu, Xin-An
    Wu, Fei
    Li, Jianqiang
    Chen, Dandan
    Li, Xiangqun
    Li, Ziyu
    Li, Jingjing
    Lu, Peihua
    BLOOD, 2020, 136
  • [22] ALLOGENEIC DONOR-DERIVED CD19-CHIMERIC ANTIGEN RECEPTOR (CAR) T CELLS FOR RELAPSED B-CELL MALIGNANCIES AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION
    Muhsen, I. N.
    Cruz, H.
    Zhang, H.
    Thakkar, S. G.
    Grilley, B.
    Gee, A. P.
    Heslop, H.
    Brenner, M.
    Ramos, C. A.
    CYTOTHERAPY, 2022, 24 (05) : S27 - S28
  • [23] Optimizing CAR-T cell therapy in adults with B-cell acute lymphoblastic leukemia
    Agrawal, Vaibhav
    Murphy, Lindsey
    Pourhassan, Hoda
    Pullarkat, Vinod
    Aldoss, Ibrahim
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2024, 112 (02) : 236 - 247
  • [24] Allogeneic Donor-Derived CD19-Chimeric Antigen Receptor (CAR) T Cells for Relapsed B-Cell Malignancies After Hematopoietic Stem Cell Transplantation
    Muhsen, Ibrahim N.
    Cruz, Helton
    Zhang, Huimin
    Thakkar, Sachin G.
    Grilley, Bambi
    Gee, Adrian P.
    Heslop, Helen E.
    Brenner, Malcolm K.
    Ramos, Carlos A.
    MOLECULAR THERAPY, 2022, 30 (04) : 227 - 227
  • [25] Allogeneic stem cell transplantation combined with conditioning regimen including donor-derived CAR-T cells for refractory/relapsed B-cell lymphoma
    Yang, Fan
    Shi, Hui
    Xu, Teng
    Liu, Rui
    Lei, Yang
    Li, Ruiting
    Deng, Biping
    Wu, Tong
    Ke, Xiaoyan
    Hu, Kai
    BONE MARROW TRANSPLANTATION, 2023, 58 (04) : 440 - 442
  • [26] The Efficacy of Chidamide Maintenance Therapy after CAR-T Therapy for Refractory or Relapsed B-Cell Acute Lymphoblastic Leukemia
    Zhang, Xian
    Huang, Lefu
    Zhang, Gailing
    Su, Yunchao
    Hu, Xiaona
    Xia, Shulian
    Li, Jingjing
    Lu, Peihua
    BLOOD, 2022, 140 : 8884 - 8885
  • [27] Allogeneic stem cell transplantation combined with conditioning regimen including donor-derived CAR-T cells for refractory/relapsed B-cell lymphoma
    Fan Yang
    Hui Shi
    Teng Xu
    Rui Liu
    Yang Lei
    Ruiting Li
    Biping Deng
    Tong Wu
    Xiaoyan Ke
    Kai Hu
    Bone Marrow Transplantation, 2023, 58 : 440 - 442
  • [28] CD19-CAR-T Therapy Followed By Allogeneic Hematopoietic Stem Cell Transplantation in Refractory/Relapsed and High Risk B-Cell Acute Lymphoblastic Leukemia
    Zhao, Yanli
    Zhang, Jianping
    Liu, Deyan
    Xiong, Min
    Wei, Zhijie
    Sun, Ruijuan
    Zhou, Jiarui
    Lu, Yue
    Cao, Xingyu
    Yang, Junfang
    Zhang, Xian
    Wang, Hui
    Liu, Hongxing
    Lu, Peihua
    Lu, Daopei
    BLOOD, 2018, 132
  • [29] Prominent efficacy and good safety of sequential CD19 and CD22 CAR-T therapy in relapsed/refractory adult B-cell acute lymphoblastic leukemia
    Tingting Yang
    Yetian Dong
    Mingming Zhang
    Jingjing Feng
    Shan Fu
    Pingnan Xiao
    Ruimin Hong
    Huijun Xu
    Jiazhen Cui
    Simao Huang
    Guoqing Wei
    Delin Kong
    Jia Geng
    Alex H. Chang
    He Huang
    Yongxian Hu
    Experimental Hematology & Oncology, 14 (1)
  • [30] Anti-CD19/CD22 Dual CAR-T Therapy for Refractory and Relapsed B-Cell Acute Lymphoblastic Leukemia
    Yang, Junfang
    Jiang, Pengfei
    Zhang, Xian
    Zhu, Xiaobin
    Dong, Qi
    He, Jiaping
    Lin, Nanjing
    Wang, Zhenguang
    Cai, Songbai
    Ye, Xun
    Su, Yunchao
    Li, Wenqian
    Li, Jingjing
    Yu, Ziyao
    He, Jiujiang
    Xu, Li
    Song, Dan
    Cao, Wei
    Lu, Peihua
    BLOOD, 2019, 134
12345